|
Volumn 49, Issue 3, 2006, Pages 475-477
|
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials - Commentary
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCG VACCINE;
BIOLOGICAL MARKER;
AGE DISTRIBUTION;
BLADDER CANCER;
CANCER GRADING;
CANCER INVASION;
CANCER RISK;
CANCER STAGING;
CARCINOMA IN SITU;
CHEMOTHERAPY;
CLINICAL TRIAL;
CYSTECTOMY;
HUMAN;
META ANALYSIS;
NOTE;
PRIORITY JOURNAL;
PROGNOSIS;
RECURRENT DISEASE;
SYSTEMATIC REVIEW;
TRANSURETHRAL RESECTION;
|
EID: 32944458263
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (108)
|
References (0)
|